nach oben

Current Infectious Disease Reports

Erschienen in:

01.10.2018 | Skin, Soft Tissue, Bone and Joint Infectious Disease (N Safdar and A Pop-Vicas, Section Editors)

Diabetic Foot Infections: Update on Management

verfasst von: Maria Nikoloudi, Ioanna Eleftheriadou, Anastasios Tentolouris, Ourania A. Kosta, Nikolaos Tentolouris

Erschienen in: Current Infectious Disease Reports | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Diabetic foot infections (DFIs) are common in patients with diabetes mellitus complicated by foot ulcers and can be classified in different categories based on their severity. In this report, we present the diagnosis and management of DFIs according to their classification.

Recent Findings

While appropriate antibiotic regiments and surgical techniques for the treatment of DFIs are well established, new technologies and techniques for example in medical imaging, wound care modalities, and supplementary therapy approaches show potentially promising results in preventing DFIs.

Summary

As with every complex disease, fine tuning DFI management can be challenging as it requires careful evaluation of different parameters. It demands timely action, close collaboration of different specialties, and patient cooperation.

Raspovic KM, Wukich DK. Self-reported quality of life and diabetic foot infections. J Foot Ankle Surg. 2014;53(6):716–9. https://doi.org/10.1053/j.jfas.2014.06.011.CrossRefPubMed

Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51(10):1826–34. https://doi.org/10.1007/s00125-008-1089-6.CrossRefPubMed

Morbach S, Furchert H, Groblinghoff U, Hoffmeier H, Kersten K, Klauke GT, et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care. 2012;35(10):2021–7. https://doi.org/10.2337/dc12-0200.CrossRefPubMedPubMedCentral

Peters EJ, Lipsky BA. Diagnosis and management of infection in the diabetic foot. Med Clin N Am. 2013;97(5):911–46. https://doi.org/10.1016/j.mcna.2013.04.005.CrossRefPubMed

Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29(6):1288–93. https://doi.org/10.2337/dc05-2425.CrossRefPubMed

• Lipsky BA, Aragon-Sanchez J, Diggle M, Embil J, Kono S, Lavery L, et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev. 2016;32(Suppl 1):45–74. https://doi.org/10.1002/dmrr.2699. This is an important article describing the recommendations of the International Working Group on The Diabetic Foot for the diagnosis, classification of the severity, and management of diabetic foor infections. CrossRefPubMed

• Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132–73. https://doi.org/10.1093/cid/cis346. This article describes the Infectious Diseases Society of America clinical practice guidelines for the diagnosis and treatment of diabetic foot infections. The reader can find useful information for the diagnosis, classification, and management of diabetic foot infections. CrossRefPubMed

Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28(Suppl 1):8–14. https://doi.org/10.1002/dmrr.2239.CrossRefPubMed

American Diabetes A. 10. Microvascular complications and foot care. Diabetes Care. 2017;40(Suppl 1):S88–98. https://doi.org/10.2337/dc17-S013.CrossRef

10.

Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–54. https://doi.org/10.2337/dc16-2042.CrossRefPubMed

11.

Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K, International Working Group on the Diabetic F. Prevention and management of foot problems in diabetes: a Summary Guidance for Daily Practice 2015, based on the IWGDF Guidance Documents. Diabetes Metab Res Rev. 2016;32(Suppl 1):7–15. https://doi.org/10.1002/dmrr.2695.CrossRefPubMed

12.

Garwood CS, Steinberg JS. What's new in wound treatment: a critical appraisal. Diabetes Metab Res Rev. 2016;32(Suppl 1):268–74. https://doi.org/10.1002/dmrr.2747. CrossRefPubMed

13.

Lewis J, Lipp A. Pressure-relieving interventions for treating diabetic foot ulcers. Cochrane Database Syst Rev. 2013;1:CD002302. https://doi.org/10.1002/14651858.CD002302.pub2.CrossRef

14.

Price P. How can we improve adherence? Diabetes Metab Res Rev. 2016;32(Suppl 1):201–5. https://doi.org/10.1002/dmrr.2744. CrossRefPubMed

15.

American Diabetes A. Standards of medical care in diabetes--2014. Diabetes Care. 2014;37(Suppl 1):S14–80. https://doi.org/10.2337/dc14-S014.CrossRef

16.

Karthikesalingam A, Holt PJ, Moxey P, Jones KG, Thompson MM, Hinchliffe RJ. A systematic review of scoring systems for diabetic foot ulcers. Diabet Med. 2010;27(5):544–9. https://doi.org/10.1111/j.1464-5491.2010.02989.x.CrossRefPubMed

17.

Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev. 2004;20(Suppl 1):S90–5. https://doi.org/10.1002/dmrr.464.CrossRefPubMed

18.

Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infectious Diseases Society of America’s diabetic foot infection classification system. Clin Infect Dis. 2007;44(4):562–5. https://doi.org/10.1086/511036.CrossRefPubMed

19.

Peters BM, Jabra-Rizk MA, O’May GA, Costerton JW, Shirtliff ME. Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev. 2012;25(1):193–213. https://doi.org/10.1128/CMR.00013-11. CrossRefPubMedPubMedCentral

20.

Sapico FL, Witte JL, Canawati HN, Montgomerie JZ, Bessman AN. The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. Rev Infect Dis. 1984;6(Suppl 1):S171–6.CrossRefPubMed

21.

Charles PG, Uckay I, Kressmann B, Emonet S, Lipsky BA. The role of anaerobes in diabetic foot infections. Anaerobe. 2015;34:8–13. https://doi.org/10.1016/j.anaerobe.2015.03.009.CrossRefPubMed

22.

Tentolouris N, Jude EB, Smirnof I, Knowles EA, Boulton AJ. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med. 1999;16(9):767–71.CrossRefPubMed

23.

Ge Y, MacDonald D, Hait H, Lipsky B, Zasloff M, Holroyd K. Microbiological profile of infected diabetic foot ulcers. Diabet Med. 2002;19(12):1032–4.CrossRefPubMed

24.

Ramakant P, Verma AK, Misra R, Prasad KN, Chand G, Mishra A, et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia. 2011;54(1):58–64. https://doi.org/10.1007/s00125-010-1893-7.CrossRefPubMed

25.

Uckay I, Gariani K, Pataky Z, Lipsky BA. Diabetic foot infections: state-of-the-art. Diabetes Obes Metab. 2014;16(4):305–16. https://doi.org/10.1111/dom.12190.CrossRefPubMed

26.

Uckay I, Aragon-Sanchez J, Lew D, Lipsky BA. Diabetic foot infections: what have we learned in the last 30 years? Int J Infect Dis. 2015;40:81–91. https://doi.org/10.1016/j.ijid.2015.09.023.CrossRefPubMed

27.

Lavigne JP, Sotto A, Dunyach-Remy C, Lipsky BA. New molecular techniques to study the skin microbiota of diabetic foot ulcers. Adv Wound Care (New Rochelle). 2015;4(1):38–49. https://doi.org/10.1089/wound.2014.0532.CrossRef

28.

Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha Van G, Golmard JL, Jarlier V, et al. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabet Med. 2004;21(7):710–5. https://doi.org/10.1111/j.1464-5491.2004.01237.x.CrossRefPubMed

29.

• Eleftheriadou I, Tentolouris N, Argiana V, Jude E, Boulton AJ. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs. 2010;70(14):1785–97. https://doi.org/10.2165/11538070-000000000-00000. This review article underlines the problem of the diabetic foot infections caused by multidrug resistance organisms and the ways for prevention and management. CrossRefPubMed

30.

Tentolouris N, Petrikkos G, Vallianou N, Zachos C, Daikos GL, Tsapogas P, et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect. 2006;12(2):186–9. https://doi.org/10.1111/j.1469-0691.2005.01279.x.CrossRefPubMed

31.

Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg. 1996;35(4):280–3.CrossRefPubMed

32.

Uzun G, Solmazgul E, Curuksulu H, Turhan V, Ardic N, Top C, et al. Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J Exp Med. 2007;213(4):305–12.CrossRefPubMed

33.

Jeandrot A, Richard JL, Combescure C, Jourdan N, Finge S, Rodier M, et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia. 2008;51(2):347–52. https://doi.org/10.1007/s00125-007-0840-8.CrossRefPubMed

34.

Park JH, Suh DH, Kim HJ, Lee YI, Kwak IH, Choi GW. Role of procalcitonin in infected diabetic foot ulcer. Diabetes Res Clin Pract. 2017;128:51–7. https://doi.org/10.1016/j.diabres.2017.04.008.CrossRefPubMed

35.

Grigoropoulou P, Eleftheriadou I, Jude EB, Tentolouris N. Diabetic foot infections: an update in diagnosis and management. Curr Diab Rep. 2017;17(1):3. https://doi.org/10.1007/s11892-017-0831-1.CrossRefPubMed

36.

Akbari R, Javaniyan M, Fahimi A, Sadeghi M. Renal function in patients with diabetic foot infection; does antibiotherapy affect it? J Renal Inj Prev. 2017;6(2):117–21. https://doi.org/10.15171/jrip.2017.23. CrossRefPubMed

37.

Peterson N, Widnall J, Evans P, Jackson G, Platt S. Diagnostic imaging of diabetic foot disorders. Foot Ankle Int. 2017;38(1):86–95. https://doi.org/10.1177/1071100716672660.CrossRefPubMed

38.

Nelson EA, Backhouse MR, Bhogal MS, Wright-Hughes A, Lipsky BA, Nixon J, et al. Concordance in diabetic foot ulcer infection. BMJ Open. 2013;3(1):e002370. https://doi.org/10.1136/bmjopen-2012-002370.CrossRefPubMedPubMedCentral

39.

Bonham PA. Swab cultures for diagnosing wound infections: a literature review and clinical guideline. J Wound Ostomy Continence Nurs. 2009;36(4):389–95. https://doi.org/10.1097/WON.0b013e3181aaef7f.CrossRefPubMed

40.

Sapico FL, Canawati HN, Witte JL, Montgomerie JZ, Wagner FW Jr, Bessman AN. Quantitative aerobic and anaerobic bacteriology of infected diabetic feet. J Clin Microbiol. 1980;12(3):413–20.PubMedPubMedCentral

41.

Slater RA, Lazarovitch T, Boldur I, Ramot Y, Buchs A, Weiss M, et al. Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone. Diabet Med. 2004;21(7):705–9. https://doi.org/10.1111/j.1464-5491.2004.01221.x.CrossRefPubMed

42.

Pellizzer G, Strazzabosco M, Presi S, Furlan F, Lora L, Benedetti P, et al. Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med. 2001;18(10):822–7.CrossRefPubMed

43.

Kalish J, Hamdan A. Management of diabetic foot problems. J Vasc Surg. 2010;51(2):476–86. https://doi.org/10.1016/j.jvs.2009.08.043.CrossRefPubMed

44.

Jude EB, Unsworth PF. Optimal treatment of infected diabetic foot ulcers. Drugs Aging. 2004;21(13):833–50.CrossRefPubMed

45.

Lipsky BA. Diabetic foot infections: current treatment and delaying the ‘post-antibiotic era’. Diabetes Metab Res Rev. 2016;32(Suppl 1):246–53. https://doi.org/10.1002/dmrr.2739. CrossRefPubMed

46.

Selva Olid A, Sola I, Barajas-Nava LA, Gianneo OD, Bonfill Cosp X, Lipsky BA. Systemic antibiotics for treating diabetic foot infections. Cochrane Database Syst Rev. 2015;9:CD009061. https://doi.org/10.1002/14651858.CD009061.pub2.CrossRef

47.

Lipsky BA, Hoey C. Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis. 2009;49(10):1541–9. https://doi.org/10.1086/644732.CrossRefPubMed

48.

Moura LI, Dias AM, Carvalho E, de Sousa HC. Recent advances on the development of wound dressings for diabetic foot ulcer treatment—a review. Acta Biomater. 2013;9(7):7093–114. https://doi.org/10.1016/j.actbio.2013.03.033.CrossRefPubMed

49.

Armstrong DG, Lavery LA, Diabetic Foot Study C. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005;366(9498):1704–10. https://doi.org/10.1016/S0140-6736(05)67695-7.CrossRefPubMed

50.

Armstrong DG, Lavery LA, Boulton AJ. Negative pressure wound therapy via vacuum-assisted closure following partial foot amputation: what is the role of wound chronicity? Int Wound J. 2007;4(1):79–86. https://doi.org/10.1111/j.1742-481X.2006.00270.x.CrossRefPubMed

51.

Kim PJ, Attinger CE, Steinberg JS, Evans KK, Powers KA, Hung RW, et al. The impact of negative-pressure wound therapy with instillation compared with standard negative-pressure wound therapy: a retrospective, historical, cohort, controlled study. Plast Reconstr Surg. 2014;133(3):709–16. https://doi.org/10.1097/01.prs.0000438060.46290.7a.CrossRefPubMed

52.

Londahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010;33(5):998–1003. https://doi.org/10.2337/dc09-1754.CrossRefPubMedPubMedCentral

53.

Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE, Weibel S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2015;6:CD004123. https://doi.org/10.1002/14651858.CD004123.pub4.CrossRef

54.

Cazander G, Pawiroredjo JS, Vandenbroucke-Grauls CM, Schreurs MW, Jukema GN. Synergism between maggot excretions and antibiotics. Wound Repair Regen. 2010;18(6):637–42. https://doi.org/10.1111/j.1524-475X.2010.00625.x.CrossRefPubMed

55.

Sun X, Jiang K, Chen J, Wu L, Lu H, Wang A, et al. A systematic review of maggot debridement therapy for chronically infected wounds and ulcers. Int J Infect Dis. 2014;25:32–7. https://doi.org/10.1016/j.ijid.2014.03.1397.CrossRefPubMed

56.

Cruciani M, Lipsky BA, Mengoli C, de Lalla F. Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections. Cochrane Database Syst Rev. 2013;8:CD006810. https://doi.org/10.1002/14651858.CD006810.pub3.CrossRef

57.

Wukich DK, Hobizal KB, Brooks MM. Severity of diabetic foot infection and rate of limb salvage. Foot Ankle Int. 2013;34(3):351–8. https://doi.org/10.1177/1071100712467980.CrossRefPubMedPubMedCentral

58.

Aragon-Sanchez J. Seminar review: a review of the basis of surgical treatment of diabetic foot infections. Int J Low Extrem Wounds. 2011;10(1):33–65. https://doi.org/10.1177/1534734611400259.CrossRefPubMed

59.

Lavery LA, Peters EJ, Armstrong DG, Wendel CS, Murdoch DP, Lipsky BA. Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract. 2009;83(3):347–52. https://doi.org/10.1016/j.diabres.2008.11.030.CrossRefPubMed

60.

Berendt AR, Peters EJ, Bakker K, Embil JM, Eneroth M, Hinchliffe RJ, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev. 2008;24(Suppl 1):S145–61. https://doi.org/10.1002/dmrr.836.CrossRefPubMed

61.

Lam K, van Asten SA, Nguyen T, La Fontaine J, Lavery LA. Diagnostic accuracy of probe to bone to detect osteomyelitis in the diabetic foot: a systematic review. Clin Infect Dis. 2016;63(7):944–8. https://doi.org/10.1093/cid/ciw445.CrossRefPubMed

62.

Senneville E. Editorial commentary: probe-to-bone test for detecting diabetic foot osteomyelitis: rapid, safe, and accurate-but for which patients? Clin Infect Dis. 2016;63(7):949–50. https://doi.org/10.1093/cid/ciw450.CrossRefPubMed

63.

Victoria van Asten SA, Geradus Peters EJ, Xi Y, Lavery LA. The role of biomarkers to diagnose diabetic foot osteomyelitis. A meta-analysis. Curr Diabetes Rev. 2016;12(4):396–402.CrossRefPubMed

64.

Kaleta JL, Fleischli JW, Reilly CH. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: a pilot study. J Am Podiatr Med Assoc. 2001;91(9):445–50.CrossRefPubMed

65.

Ertugrul BM, Savk O, Ozturk B, Cobanoglu M, Oncu S, Sakarya S. The diagnosis of diabetic foot osteomyelitis: examination findings and laboratory values. Med Sci Monit. 2009;15(6):CR307–12.PubMed

66.

Michail M, Jude E, Liaskos C, Karamagiolis S, Makrilakis K, Dimitroulis D, et al. The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis. Int J Low Extrem Wounds. 2013;12(2):94–9. https://doi.org/10.1177/1534734613486152.CrossRefPubMed

67.

Dinh MT, Abad CL, Safdar N. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clin Infect Dis. 2008;47(4):519–27. https://doi.org/10.1086/590011.CrossRefPubMed

68.

Schinabeck MK, Johnson JL. Osteomyelitis in diabetic foot ulcers. Prompt diagnosis can avert amputation. Postgrad Med. 2005;118(1):11–5.CrossRefPubMed

69.

Ertugrul BM, Lipsky BA, Savk O. Osteomyelitis or Charcot neuro-osteoarthropathy? Differentiating these disorders in diabetic patients with a foot problem. Diabet Foot Ankle. 2013;4 https://doi.org/10.3402/dfa.v4i0.21855.

70.

Hartemann-Heurtier A, Senneville E. Diabetic foot osteomyelitis. Diabete Metab. 2008;34(2):87–95. https://doi.org/10.1016/j.diabet.2007.09.005.CrossRefPubMed

71.

• Basu S, Chryssikos T, Houseni M, Scot Malay D, Shah J, Zhuang H, et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot’s neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun. 2007;28(6):465–72. https://doi.org/10.1097/MNM.0b013e328174447f. This is a novel study describing the performance of various methods, including FDG PET scan for the differemtial diagnosis of osteomyelitis and Charcot foot. CrossRefPubMed

72.

Lipsky BA, Peters EJ, Senneville E, Berendt AR, Embil JM, Lavery LA, et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev. 2012;28(Suppl 1):163–78. https://doi.org/10.1002/dmrr.2248. CrossRefPubMed

73.

Peters EJ. Pitfalls in diagnosing diabetic foot infections. Diabetes Metab Res Rev. 2016;32(Suppl 1):254–60. https://doi.org/10.1002/dmrr.2736. CrossRefPubMed

74.

Lazaro-Martinez JL, Aragon-Sanchez J, Garcia-Morales E. Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial. Diabetes Care. 2014;37(3):789–95. https://doi.org/10.2337/dc13-1526.CrossRefPubMed

75.

Lesens O, Desbiez F, Theis C, Ferry T, Bensalem M, Laurichesse H, et al. Staphylococcus aureus-related diabetic osteomyelitis: medical or surgical management? A French and Spanish retrospective cohort. Int J Low Extrem Wounds. 2015;14(3):284–90. https://doi.org/10.1177/1534734614559931.CrossRefPubMed

76.

Widatalla AH, Mahadi SE, Shawer MA, Mahmoud SM, Abdelmageed AE, Ahmed ME. Diabetic foot infections with osteomyelitis: efficacy of combined surgical and medical treatment. Diabet Foot Ankle. 2012;3 https://doi.org/10.3402/dfa.v3i0.18809.

77.

Bus SA, van Netten JJ. A shift in priority in diabetic foot care and research: 75% of foot ulcers are preventable. Diabetes Metab Res Rev. 2016;32(Suppl 1):195–200. https://doi.org/10.1002/dmrr.2738. CrossRefPubMed

Titel: Diabetic Foot Infections: Update on Management
verfasst von: Maria Nikoloudi
Ioanna Eleftheriadou
Anastasios Tentolouris
Ourania A. Kosta
Nikolaos Tentolouris
Publikationsdatum: 01.10.2018
Verlag: Springer US
Erschienen in: Current Infectious Disease Reports / Ausgabe 10/2018
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI: https://doi.org/10.1007/s11908-018-0645-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Diabetic Foot Infections: Update on Management